𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis

✍ Scribed by Nathalie Théret; Orlando Musso; Jean Pierre Campion; Bruno Turlin; Olivier Loréal; Annie L'helgoualc′h; Bruno Clément

Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
293 KB
Volume
74
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Degradation of basement membranes is a key step in tumoral invasion, mainly mediated by matrix metalloproteinases (MMPs) and their inhibitors (TIMPs). Since the liver is a main target for metastases from gastrointestinal adenocarcinoma, we have investigated MMP2 and TIMP2 expression by RT-PCR, in situ hybridization and zymography in the liver of patients with gastrointestinal adenocarcinomas and no detectable hepatic metastasis (n = 12), in tumoral and nontumoral liver from patients with hepatic metastasis (n = 9) and in control liver (n = 4). MMP2 and TIMP2 mRNA levels were increased in liver from patients with gastrointestinal adenocarcinomas and no detectable metastasis, compared with those of either control liver (5-fold and 3.2-fold, respectively) or nontumoral areas of liver from patients with metastasis (7.8-fold and 3-fold, respectively). MMP2 and TIMP2 transcripts were located in mesenchymal cells of portal tracts and sinusoids. MMP2 was mainly in its latent form. In liver from patients with hepatic metastasis, the tumoral/nontumoral ratios for MMP2 and TIMP2 mRNA were 6.2 +/- 4 and 1.5 +/- 0.4, respectively. Both transcripts were localized in the stromal cells of liver metastases, and the active form of MMP2 was found only in the tumoral areas. In the matching nontumoral areas the signals for MMP2 and TIMP2 mRNA were restricted to mesenchymal cells in portal tracts and sinusoidal cells. Our data show that liver stromal cells express high levels of MMP2 and TIMP2 in patients with colonic carcinoma without liver metastasis, suggesting the distant induction of these transcripts by the primary tumor.

📜 SIMILAR VOLUMES

Prognostic values of matrix metalloprote
Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
✍ Hiro-omi Kanayama; Kin-ya Yokota; Yasushi Kurokawa; Yoshihide Murakami; Masaaki 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

## Background: Matrix metalloproteinase-2 (mmp-2), which degrades the extracellular matrix or the basement membrane, has an essential role in tumor invasion and metastasis. to evaluate the roles of mmp-2, its inhibitor (tissue inhibitor of metalloproteinase-2 [timp-2]), and its activator (membrane-

Matrix metalloproteinases 1 and 3, tissu
Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer
✍ Klaus Jung; Lars Nowak; Michael Lein; Friedrich Priem; Dietmar Schnorr; Stefan A 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 74 KB

We analyzed blood plasma concentrations of matrix metalloproteinase-1 and -3 (MMP-1; MMP-3), the tissue inhibitor of metalloproteinase-1 (TIMP-1) and the complex MMP-1/ TIMP-1, and looked for any correlation with prostate cancer stage. These components were measured by ELISA tests specific for these

Expression of tissue inhibitor of matrix
Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma
✍ Tomokazu Yoshizaki; Yumiko Maruyama; Hiroshi Sato; Mitsuru Furukawa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 321 KB 👁 2 views

Matrix metalloproteinase 2 (MMP-2) plays a crucial role in invasion and metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) was originally identified as an activator of MMP-2. Tissue inhibitor of MMP-2 (TIMP-2) was identified as an inhibitor of MMP-2 and MT1-MMP. However, TIMP-2 was report

Matrix metalloproteinases and tissue inh
Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints
✍ Takei, Isao ;Takagi, Michiaki ;Santavirta, Seppo ;Ida, Hideo ;Hamasaki, Makoto ; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

The pseudojoint cavity formed in patients undergoing total hip arthroplasty (THA) is later remodeled to synovial membrane-like tissue, which produces pseudosynovial fluid. This pseudosynovium also is an important source of matrix metalloproteinases (MMPs). As it is widely speculated that synovial fl

Matrix-metalloproteinases and their inhi
Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinoma
✍ Michael Lein; Klaus Jung; Christian Laube; Tobias Hübner; Bjoern Winkelmann; Car 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 70 KB 👁 1 views

Matrix-metalloproteinases (MMPs) are associated with invasive and metastatic behavior of several human malignant tumors. We have determined MMP-2 and MMP-9 and tissue inhibitors of MMPs (TIMP-1 and TIMP-2) in blood plasma and in renal tissue samples of patients with renal cell carcinoma (RCC) from c

Tissue inhibitor of matrix metalloprotei
Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma : A possible marker for serosal invasion and metastasis
✍ Takaki Yoshikawa; Mitsunori Saitoh; Akira Tsuburaya; Osamu Kobayashi; Motonori S 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## BACKGROUND. Expression of the tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in tumor tissue from patients with gastric carcinoma has been reported to be related to disease progression. However, to the authors' knowledge the clinical significance of plasma TIMP-1 concentrations in these